nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Lactic dehydrogenase activity increased—Epirubicin—peripheral nervous system neoplasm	0.00662	0.00713	CcSEcCtD
Fenoldopam—Nasal congestion—Alitretinoin—peripheral nervous system neoplasm	0.00617	0.00665	CcSEcCtD
Fenoldopam—Lactic dehydrogenase activity increased—Doxorubicin—peripheral nervous system neoplasm	0.00612	0.0066	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Epirubicin—peripheral nervous system neoplasm	0.00583	0.00628	CcSEcCtD
Fenoldopam—Cardiac failure—Alitretinoin—peripheral nervous system neoplasm	0.00576	0.0062	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Tretinoin—peripheral nervous system neoplasm	0.00563	0.00607	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00563	0.00607	CcSEcCtD
Fenoldopam—Myocardial infarction—Tretinoin—peripheral nervous system neoplasm	0.0056	0.00603	CcSEcCtD
Fenoldopam—Myocardial infarction—Isotretinoin—peripheral nervous system neoplasm	0.0056	0.00603	CcSEcCtD
Fenoldopam—Transaminases increased—Epirubicin—peripheral nervous system neoplasm	0.00557	0.006	CcSEcCtD
Fenoldopam—Urinary tract infection—Tretinoin—peripheral nervous system neoplasm	0.00555	0.00598	CcSEcCtD
Fenoldopam—Urinary tract infection—Isotretinoin—peripheral nervous system neoplasm	0.00555	0.00598	CcSEcCtD
Fenoldopam—Sweating—Topotecan—peripheral nervous system neoplasm	0.00552	0.00595	CcSEcCtD
Fenoldopam—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.00548	0.0059	CcSEcCtD
Fenoldopam—Sweating—Tretinoin—peripheral nervous system neoplasm	0.00548	0.0059	CcSEcCtD
Fenoldopam—Blood lactate dehydrogenase increased—Doxorubicin—peripheral nervous system neoplasm	0.00539	0.00581	CcSEcCtD
Fenoldopam—Blood creatinine increased—Alitretinoin—peripheral nervous system neoplasm	0.00526	0.00567	CcSEcCtD
Fenoldopam—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.00525	0.00566	CcSEcCtD
Fenoldopam—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.0052	0.0056	CcSEcCtD
Fenoldopam—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00517	0.00557	CcSEcCtD
Fenoldopam—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00515	0.00555	CcSEcCtD
Fenoldopam—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00515	0.00555	CcSEcCtD
Fenoldopam—Transaminases increased—Doxorubicin—peripheral nervous system neoplasm	0.00515	0.00555	CcSEcCtD
Fenoldopam—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00513	0.00553	CcSEcCtD
Fenoldopam—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00513	0.00553	CcSEcCtD
Fenoldopam—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00509	0.00548	CcSEcCtD
Fenoldopam—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00506	0.00545	CcSEcCtD
Fenoldopam—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00476	0.00513	CcSEcCtD
Fenoldopam—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00476	0.00513	CcSEcCtD
Fenoldopam—Flushing—Melphalan—peripheral nervous system neoplasm	0.0047	0.00506	CcSEcCtD
Fenoldopam—Cardiac failure—Etoposide—peripheral nervous system neoplasm	0.00449	0.00484	CcSEcCtD
Fenoldopam—Blood creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.00448	0.00483	CcSEcCtD
Fenoldopam—Tension—Tretinoin—peripheral nervous system neoplasm	0.00438	0.00472	CcSEcCtD
Fenoldopam—Tension—Isotretinoin—peripheral nervous system neoplasm	0.00438	0.00472	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.00437	0.00471	CcSEcCtD
Fenoldopam—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.00436	0.00469	CcSEcCtD
Fenoldopam—Back pain—Topotecan—peripheral nervous system neoplasm	0.00435	0.00469	CcSEcCtD
Fenoldopam—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.00434	0.00467	CcSEcCtD
Fenoldopam—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.00434	0.00467	CcSEcCtD
Fenoldopam—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00433	0.00466	CcSEcCtD
Fenoldopam—Back pain—Tretinoin—peripheral nervous system neoplasm	0.00432	0.00465	CcSEcCtD
Fenoldopam—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.00432	0.00465	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00427	0.0046	CcSEcCtD
Fenoldopam—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.00424	0.00457	CcSEcCtD
Fenoldopam—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00421	0.00453	CcSEcCtD
Fenoldopam—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00415	0.00447	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Vincristine—peripheral nervous system neoplasm	0.00411	0.00443	CcSEcCtD
Fenoldopam—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.00409	0.00441	CcSEcCtD
Fenoldopam—Sweating—Vincristine—peripheral nervous system neoplasm	0.004	0.00431	CcSEcCtD
Fenoldopam—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00395	0.00425	CcSEcCtD
Fenoldopam—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00395	0.00425	CcSEcCtD
Fenoldopam—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00391	0.00421	CcSEcCtD
Fenoldopam—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00389	0.00419	CcSEcCtD
Fenoldopam—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00389	0.00419	CcSEcCtD
Fenoldopam—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00383	0.00413	CcSEcCtD
Fenoldopam—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.0038	0.0041	CcSEcCtD
Fenoldopam—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.0038	0.0041	CcSEcCtD
Fenoldopam—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00379	0.00408	CcSEcCtD
Fenoldopam—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00379	0.00408	CcSEcCtD
Fenoldopam—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00375	0.00404	CcSEcCtD
Fenoldopam—Oliguria—Epirubicin—peripheral nervous system neoplasm	0.00367	0.00396	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.00364	0.00392	CcSEcCtD
Fenoldopam—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.00362	0.0039	CcSEcCtD
Fenoldopam—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00361	0.00389	CcSEcCtD
Fenoldopam—Creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00383	CcSEcCtD
Fenoldopam—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00356	0.00383	CcSEcCtD
Fenoldopam—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00356	0.00383	CcSEcCtD
Fenoldopam—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00355	0.00383	CcSEcCtD
Fenoldopam—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00352	0.0038	CcSEcCtD
Fenoldopam—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00352	0.0038	CcSEcCtD
Fenoldopam—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00351	0.00378	CcSEcCtD
Fenoldopam—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.0034	0.00367	CcSEcCtD
Fenoldopam—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.0034	0.00367	CcSEcCtD
Fenoldopam—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.0034	0.00366	CcSEcCtD
Fenoldopam—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00337	0.00363	CcSEcCtD
Fenoldopam—Injection site reaction—Epirubicin—peripheral nervous system neoplasm	0.00337	0.00363	CcSEcCtD
Fenoldopam—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00336	0.00362	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.00333	0.00359	CcSEcCtD
Fenoldopam—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00332	0.00358	CcSEcCtD
Fenoldopam—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.00331	0.00357	CcSEcCtD
Fenoldopam—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.0033	0.00355	CcSEcCtD
Fenoldopam—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.0033	0.00355	CcSEcCtD
Fenoldopam—Creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00355	CcSEcCtD
Fenoldopam—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00329	0.00354	CcSEcCtD
Fenoldopam—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00327	0.00353	CcSEcCtD
Fenoldopam—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.00327	0.00353	CcSEcCtD
Fenoldopam—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00325	0.0035	CcSEcCtD
Fenoldopam—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00325	0.0035	CcSEcCtD
Fenoldopam—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00321	0.00345	CcSEcCtD
Fenoldopam—Blood urea increased—Epirubicin—peripheral nervous system neoplasm	0.0032	0.00345	CcSEcCtD
Fenoldopam—Back pain—Vincristine—peripheral nervous system neoplasm	0.00315	0.0034	CcSEcCtD
Fenoldopam—Constipation—Topotecan—peripheral nervous system neoplasm	0.00314	0.00338	CcSEcCtD
Fenoldopam—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00312	0.00336	CcSEcCtD
Fenoldopam—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00312	0.00336	CcSEcCtD
Fenoldopam—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00311	0.00336	CcSEcCtD
Fenoldopam—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00307	0.00331	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.003	0.00324	CcSEcCtD
Fenoldopam—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00299	0.00322	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00298	0.00321	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00298	0.00321	CcSEcCtD
Fenoldopam—Blood urea increased—Doxorubicin—peripheral nervous system neoplasm	0.00296	0.00319	CcSEcCtD
Fenoldopam—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.0029	0.00313	CcSEcCtD
Fenoldopam—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.0029	0.00313	CcSEcCtD
Fenoldopam—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.0031	CcSEcCtD
Fenoldopam—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00288	0.0031	CcSEcCtD
Fenoldopam—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00288	0.0031	CcSEcCtD
Fenoldopam—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00288	0.0031	CcSEcCtD
Fenoldopam—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00288	0.0031	CcSEcCtD
Fenoldopam—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00287	0.00309	CcSEcCtD
Fenoldopam—Flushing—Etoposide—peripheral nervous system neoplasm	0.00282	0.00303	CcSEcCtD
Fenoldopam—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00277	0.00299	CcSEcCtD
Fenoldopam—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00269	0.0029	CcSEcCtD
Fenoldopam—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00267	0.00288	CcSEcCtD
Fenoldopam—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00258	0.00278	CcSEcCtD
Fenoldopam—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00257	0.00277	CcSEcCtD
Fenoldopam—Back pain—Etoposide—peripheral nervous system neoplasm	0.00255	0.00275	CcSEcCtD
Fenoldopam—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00254	0.00274	CcSEcCtD
Fenoldopam—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00252	0.00271	CcSEcCtD
Fenoldopam—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00251	0.00271	CcSEcCtD
Fenoldopam—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.00269	CcSEcCtD
Fenoldopam—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00249	0.00269	CcSEcCtD
Fenoldopam—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00249	0.00269	CcSEcCtD
Fenoldopam—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00249	0.00268	CcSEcCtD
Fenoldopam—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00246	0.00265	CcSEcCtD
Fenoldopam—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00246	0.00265	CcSEcCtD
Fenoldopam—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00245	0.00264	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00244	0.00262	CcSEcCtD
Fenoldopam—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00243	0.00262	CcSEcCtD
Fenoldopam—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00241	0.0026	CcSEcCtD
Fenoldopam—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.0026	CcSEcCtD
Fenoldopam—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00241	0.00259	CcSEcCtD
Fenoldopam—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.00254	CcSEcCtD
Fenoldopam—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00235	0.00254	CcSEcCtD
Fenoldopam—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00235	0.00254	CcSEcCtD
Fenoldopam—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00234	0.00252	CcSEcCtD
Fenoldopam—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.00233	0.00251	CcSEcCtD
Fenoldopam—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.0025	CcSEcCtD
Fenoldopam—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00232	0.0025	CcSEcCtD
Fenoldopam—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.0023	0.00248	CcSEcCtD
Fenoldopam—Headache—Topotecan—peripheral nervous system neoplasm	0.0023	0.00248	CcSEcCtD
Fenoldopam—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.0023	0.00247	CcSEcCtD
Fenoldopam—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00229	0.00246	CcSEcCtD
Fenoldopam—Headache—Tretinoin—peripheral nervous system neoplasm	0.00228	0.00246	CcSEcCtD
Fenoldopam—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00228	0.00246	CcSEcCtD
Fenoldopam—Constipation—Vincristine—peripheral nervous system neoplasm	0.00228	0.00245	CcSEcCtD
Fenoldopam—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00227	0.00245	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00243	CcSEcCtD
Fenoldopam—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00225	0.00242	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00225	0.00242	CcSEcCtD
Fenoldopam—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00224	0.00241	CcSEcCtD
Fenoldopam—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.0022	0.00237	CcSEcCtD
Fenoldopam—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00235	CcSEcCtD
Fenoldopam—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00235	CcSEcCtD
Fenoldopam—Nausea—Topotecan—peripheral nervous system neoplasm	0.00218	0.00235	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00218	0.00234	CcSEcCtD
Fenoldopam—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00216	0.00233	CcSEcCtD
Fenoldopam—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00216	0.00233	CcSEcCtD
Fenoldopam—Nausea—Melphalan—peripheral nervous system neoplasm	0.00214	0.0023	CcSEcCtD
Fenoldopam—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00213	0.0023	CcSEcCtD
Fenoldopam—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.0021	0.00227	CcSEcCtD
Fenoldopam—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.0021	0.00227	CcSEcCtD
Fenoldopam—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.0021	0.00227	CcSEcCtD
Fenoldopam—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.0021	0.00226	CcSEcCtD
Fenoldopam—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00208	0.00225	CcSEcCtD
Fenoldopam—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00224	CcSEcCtD
Fenoldopam—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00207	0.00223	CcSEcCtD
Fenoldopam—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00223	CcSEcCtD
Fenoldopam—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00204	0.0022	CcSEcCtD
Fenoldopam—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00201	0.00217	CcSEcCtD
Fenoldopam—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00192	0.00207	CcSEcCtD
Fenoldopam—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00206	CcSEcCtD
Fenoldopam—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00204	CcSEcCtD
Fenoldopam—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00204	CcSEcCtD
Fenoldopam—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00186	0.002	CcSEcCtD
Fenoldopam—Constipation—Etoposide—peripheral nervous system neoplasm	0.00184	0.00199	CcSEcCtD
Fenoldopam—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00184	0.00198	CcSEcCtD
Fenoldopam—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00197	CcSEcCtD
Fenoldopam—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00182	0.00196	CcSEcCtD
Fenoldopam—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00182	0.00196	CcSEcCtD
Fenoldopam—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00177	0.00191	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00176	0.0019	CcSEcCtD
Fenoldopam—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00176	0.0019	CcSEcCtD
Fenoldopam—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00189	CcSEcCtD
Fenoldopam—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00187	CcSEcCtD
Fenoldopam—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00173	0.00186	CcSEcCtD
Fenoldopam—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00184	CcSEcCtD
Fenoldopam—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0017	0.00184	CcSEcCtD
Fenoldopam—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.0017	0.00184	CcSEcCtD
Fenoldopam—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.0017	0.00184	CcSEcCtD
Fenoldopam—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.0017	0.00183	CcSEcCtD
Fenoldopam—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00169	0.00182	CcSEcCtD
Fenoldopam—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.00168	0.00181	CcSEcCtD
Fenoldopam—Headache—Vincristine—peripheral nervous system neoplasm	0.00167	0.0018	CcSEcCtD
Fenoldopam—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00164	0.00177	CcSEcCtD
Fenoldopam—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00173	CcSEcCtD
Fenoldopam—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.00173	CcSEcCtD
Fenoldopam—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.0017	CcSEcCtD
Fenoldopam—Nausea—Vincristine—peripheral nervous system neoplasm	0.00158	0.0017	CcSEcCtD
Fenoldopam—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00158	0.0017	CcSEcCtD
Fenoldopam—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.0017	CcSEcCtD
Fenoldopam—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0015	0.00161	CcSEcCtD
Fenoldopam—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00147	0.00159	CcSEcCtD
Fenoldopam—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00157	CcSEcCtD
Fenoldopam—Tension—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00157	CcSEcCtD
Fenoldopam—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00155	CcSEcCtD
Fenoldopam—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00143	0.00154	CcSEcCtD
Fenoldopam—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00143	0.00154	CcSEcCtD
Fenoldopam—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00153	CcSEcCtD
Fenoldopam—Nausea—Cisplatin—peripheral nervous system neoplasm	0.0014	0.00151	CcSEcCtD
Fenoldopam—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00137	0.00148	CcSEcCtD
Fenoldopam—Headache—Etoposide—peripheral nervous system neoplasm	0.00135	0.00146	CcSEcCtD
Fenoldopam—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00145	CcSEcCtD
Fenoldopam—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00143	CcSEcCtD
Fenoldopam—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00143	CcSEcCtD
Fenoldopam—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00132	0.00142	CcSEcCtD
Fenoldopam—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00141	CcSEcCtD
Fenoldopam—Nausea—Etoposide—peripheral nervous system neoplasm	0.00128	0.00138	CcSEcCtD
Fenoldopam—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00136	CcSEcCtD
Fenoldopam—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00135	CcSEcCtD
Fenoldopam—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.0013	CcSEcCtD
Fenoldopam—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00127	CcSEcCtD
Fenoldopam—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00117	0.00126	CcSEcCtD
Fenoldopam—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00126	CcSEcCtD
Fenoldopam—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00125	CcSEcCtD
Fenoldopam—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00122	CcSEcCtD
Fenoldopam—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00118	CcSEcCtD
Fenoldopam—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00118	CcSEcCtD
Fenoldopam—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00108	0.00116	CcSEcCtD
Fenoldopam—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00116	CcSEcCtD
Fenoldopam—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00113	CcSEcCtD
Fenoldopam—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00111	CcSEcCtD
Fenoldopam—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00109	CcSEcCtD
Fenoldopam—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000997	0.00107	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000988	0.00106	CcSEcCtD
Fenoldopam—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000956	0.00103	CcSEcCtD
Fenoldopam—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000955	0.00103	CcSEcCtD
Fenoldopam—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000955	0.00103	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000914	0.000985	CcSEcCtD
Fenoldopam—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.000952	CcSEcCtD
Fenoldopam—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000884	0.000952	CcSEcCtD
Fenoldopam—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000827	0.000891	CcSEcCtD
Fenoldopam—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000799	0.000861	CcSEcCtD
Fenoldopam—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000768	0.000828	CcSEcCtD
Fenoldopam—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000765	0.000824	CcSEcCtD
Fenoldopam—Headache—Epirubicin—peripheral nervous system neoplasm	0.000757	0.000816	CcSEcCtD
Fenoldopam—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.000797	CcSEcCtD
Fenoldopam—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000773	CcSEcCtD
Fenoldopam—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000711	0.000766	CcSEcCtD
Fenoldopam—Headache—Doxorubicin—peripheral nervous system neoplasm	0.0007	0.000755	CcSEcCtD
Fenoldopam—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000716	CcSEcCtD
Fenoldopam—ADRA2C—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.67e-05	0.00134	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.59e-05	0.00133	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	9.54e-05	0.00132	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	9.52e-05	0.00132	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	9.5e-05	0.00132	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	9.4e-05	0.00131	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	9.4e-05	0.00131	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.22e-05	0.00128	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.19e-05	0.00128	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	9.16e-05	0.00127	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.1e-05	0.00126	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.07e-05	0.00126	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	9.05e-05	0.00126	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.05e-05	0.00126	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	9.05e-05	0.00126	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.88e-05	0.00123	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.82e-05	0.00123	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.78e-05	0.00122	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.76e-05	0.00122	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.7e-05	0.00121	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.48e-05	0.00118	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	8.47e-05	0.00118	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	8.46e-05	0.00117	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.45e-05	0.00117	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.44e-05	0.00117	CbGpPWpGaD
Fenoldopam—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	8.41e-05	0.00117	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.37e-05	0.00116	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	8.32e-05	0.00116	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	8.22e-05	0.00114	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.2e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	8.2e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.19e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—PTPN11—peripheral nervous system neoplasm	8.13e-05	0.00113	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.07e-05	0.00112	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.96e-05	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.91e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.86e-05	0.00109	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.82e-05	0.00109	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.68e-05	0.00107	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.67e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.65e-05	0.00106	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.56e-05	0.00105	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	7.55e-05	0.00105	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	7.53e-05	0.00105	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.39e-05	0.00103	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	7.39e-05	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ENO2—peripheral nervous system neoplasm	7.31e-05	0.00102	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.27e-05	0.00101	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.18e-05	0.000998	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.17e-05	0.000996	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	7.1e-05	0.000986	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.06e-05	0.00098	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.98e-05	0.000969	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.96e-05	0.000967	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.95e-05	0.000965	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.94e-05	0.000964	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.86e-05	0.000953	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.71e-05	0.000932	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.71e-05	0.000932	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.71e-05	0.000931	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.69e-05	0.000929	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.61e-05	0.000917	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	6.6e-05	0.000917	CbGpPWpGaD
Fenoldopam—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.56e-05	0.000911	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6.46e-05	0.000897	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.4e-05	0.000889	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.37e-05	0.000885	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.29e-05	0.000873	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	6.23e-05	0.000866	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	6.21e-05	0.000863	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	6.2e-05	0.000861	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—BCHE—peripheral nervous system neoplasm	6.18e-05	0.000858	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	6.17e-05	0.000857	CbGpPWpGaD
Fenoldopam—ADRA2C—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	6.12e-05	0.000851	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	6.09e-05	0.000846	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	6e-05	0.000834	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	5.94e-05	0.000825	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.89e-05	0.000819	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.87e-05	0.000815	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—TH—peripheral nervous system neoplasm	5.81e-05	0.000807	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.73e-05	0.000796	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.67e-05	0.000788	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.61e-05	0.000779	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.53e-05	0.000768	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.45e-05	0.000757	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.45e-05	0.000757	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.38e-05	0.000747	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.3e-05	0.000736	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	5.23e-05	0.000727	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.22e-05	0.000725	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.19e-05	0.000721	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.12e-05	0.000712	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.07e-05	0.000705	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	5.02e-05	0.000697	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.99e-05	0.000694	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.98e-05	0.000692	CbGpPWpGaD
Fenoldopam—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	4.97e-05	0.000691	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	4.89e-05	0.000679	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.85e-05	0.000674	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.81e-05	0.000668	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.79e-05	0.000665	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.76e-05	0.000662	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	4.74e-05	0.000659	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	4.72e-05	0.000655	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.7e-05	0.000653	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.66e-05	0.000648	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	4.65e-05	0.000646	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.63e-05	0.000644	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.63e-05	0.000642	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.59e-05	0.000638	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.53e-05	0.00063	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.46e-05	0.00062	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.32e-05	0.0006	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.31e-05	0.000598	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.25e-05	0.000591	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.24e-05	0.00059	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.23e-05	0.000588	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.11e-05	0.000571	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.08e-05	0.000566	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	4e-05	0.000556	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	3.97e-05	0.000551	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.96e-05	0.000551	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.96e-05	0.000551	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.94e-05	0.000547	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.92e-05	0.000545	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.9e-05	0.000542	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	3.85e-05	0.000535	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	3.83e-05	0.000532	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.79e-05	0.000526	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	3.78e-05	0.000525	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.78e-05	0.000525	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	3.74e-05	0.000519	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.71e-05	0.000515	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.68e-05	0.000511	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.61e-05	0.000501	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.6e-05	0.0005	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.57e-05	0.000497	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	3.57e-05	0.000497	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.51e-05	0.000487	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.47e-05	0.000481	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	3.38e-05	0.000469	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.37e-05	0.000468	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.33e-05	0.000462	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.31e-05	0.00046	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.28e-05	0.000455	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.27e-05	0.000454	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.22e-05	0.000447	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	3.16e-05	0.000438	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	3.04e-05	0.000422	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3e-05	0.000417	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3e-05	0.000416	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.95e-05	0.00041	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	2.9e-05	0.000403	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.8e-05	0.00039	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.79e-05	0.000388	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.76e-05	0.000383	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.76e-05	0.000383	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.71e-05	0.000377	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.62e-05	0.000363	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.58e-05	0.000359	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	2.56e-05	0.000356	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.54e-05	0.000353	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.5e-05	0.000347	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.47e-05	0.000342	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.45e-05	0.000341	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.43e-05	0.000338	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.41e-05	0.000335	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.4e-05	0.000333	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.38e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.37e-05	0.000329	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.34e-05	0.000326	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.33e-05	0.000324	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.29e-05	0.000318	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000316	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000311	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.2e-05	0.000305	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000304	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.18e-05	0.000302	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.18e-05	0.000302	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.15e-05	0.000298	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.14e-05	0.000298	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.14e-05	0.000297	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.12e-05	0.000294	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.05e-05	0.000285	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.02e-05	0.00028	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.99e-05	0.000277	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.99e-05	0.000277	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.98e-05	0.000275	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.98e-05	0.000274	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.96e-05	0.000273	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.96e-05	0.000273	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.95e-05	0.00027	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.94e-05	0.000269	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.94e-05	0.000269	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.9e-05	0.000264	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.86e-05	0.000259	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.85e-05	0.000258	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.83e-05	0.000254	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.81e-05	0.000252	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.81e-05	0.000251	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.79e-05	0.000249	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.79e-05	0.000249	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.78e-05	0.000248	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.77e-05	0.000246	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.000246	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.74e-05	0.000242	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.73e-05	0.00024	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000231	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.66e-05	0.00023	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.65e-05	0.000229	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.64e-05	0.000228	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.63e-05	0.000226	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000225	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.61e-05	0.000223	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.58e-05	0.00022	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.54e-05	0.000214	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.52e-05	0.000212	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.52e-05	0.000211	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.5e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.5e-05	0.000209	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000204	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.46e-05	0.000202	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000201	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.44e-05	0.0002	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.4e-05	0.000194	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.36e-05	0.000188	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.35e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000187	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.3e-05	0.00018	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.29e-05	0.000179	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	1.28e-05	0.000178	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.27e-05	0.000176	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.25e-05	0.000174	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.25e-05	0.000173	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.21e-05	0.000168	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.19e-05	0.000166	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.15e-05	0.00016	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.15e-05	0.000159	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.11e-05	0.000154	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.1e-05	0.000153	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000149	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.06e-05	0.000147	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.05e-05	0.000146	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.04e-05	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	0.000143	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.84e-06	0.000137	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.71e-06	0.000135	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.36e-06	0.00013	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.69e-06	0.000121	CbGpPWpGaD
